Back to Research Hub
Takeda Pharmaceutical Company Limited
TAK
$15.72-0.02 (-0.13%)
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally.
StreetsValue research for Takeda Pharmaceutical Company Limited (TAK)
Members get the full report for Takeda Pharmaceutical Company Limited: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.